Casdin Capital, LLC Q1 2016 Filing
Filed May 9, 2016
Portfolio Value
$87.1B
Holdings
26
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —LOXO ONCOLOGY INC | 250,000 | $6.8B | 7.85% | |
| 2 | —EPIZYME INC | 545,000 | $6.6B | 7.58% | |
| 3 | —FOUNDATION MEDICINE INC | 335,000 | $6.1B | 6.99% | |
| 4 | SG7SAGE THERAPEUTICS INC | 189,000 | $6.1B | 6.95% | |
| 5 | AGIOAGIOS PHARMACEUTICALS INC | 148,000 | $6.0B | 6.90% | |
| 6 | 2L9BLUEPRINT MEDICINES CORP | 321,300 | $5.8B | 6.66% | |
| 7 | ALNYALNYLAM PHARMACEUTICALS INC | 90,000 | $5.6B | 6.48% | |
| 8 | —BLUEBIRD BIO INC | 120,000 | $5.1B | 5.85% | |
| 9 | —MYOKARDIA INC | 475,350 | $5.1B | 5.84% | |
| 10 | —SPARK THERAPEUTICS INC | 170,000 | $5.0B | 5.76% | |
| 11 | CTMXCYTOMX THERAPEUTICS INC | 321,023 | $4.1B | 4.75% | |
| 12 | —KITE PHARMA INC | 75,000 | $3.4B | 3.95% | |
| 13 | VYGRVOYAGER THERAPEUTICS INC | 339,362 | $3.0B | 3.40% | |
| 14 | EDITEDITAS MEDICINE INC | 85,470 | $3.0B | 3.39% | |
| 15 | DC4DEXCOM INC | 40,000 | $2.7B | 3.12% | |
| 16 | XBISPDR SERIES TRUST | 50,000 | $2.6B | 2.96% | Put |
| 17 | —AVEXIS INC | 63,000 | $1.7B | 1.97% | |
| 18 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 105,000 | $1.7B | 1.91% | |
| 19 | —GENOMIC HEALTH INC | 55,000 | $1.4B | 1.56% | |
| 20 | BMYBRISTOL MYERS SQUIBB CO | 21,000 | $1.3B | 1.54% | |
| 21 | BIIBBIOGEN INC | 5,000 | $1.3B | 1.49% | |
| 22 | ONCBEIGENE LTD | 32,500 | $953.0M | 1.09% | |
| 23 | —IGNYTA INC | 110,000 | $745.0M | 0.86% | |
| 24 | EXASEXACT SCIENCES CORP | 60,000 | $404.0M | 0.46% | |
| 25 | —MEDIDATA SOLUTIONS INC | 10,000 | $387.0M | 0.44% | |
| 26 | —OXFORD IMMUNOTEC GLOBAL PLC | 20,000 | $198.0M | 0.23% |